Iceta R, Mesonero J E, Aramayona J J, Alcalde A I
Department of Pharmacology and Physiology, Faculty of Veterinary Sciences, University of Zaragoza, Spain.
J Physiol Pharmacol. 2006 Mar;57(1):119-30.
The serotonin transporter (SERT) has shown itself to be an effective pharmacological target in the treatment of mood disorders and some kinds of gastrointestinal syndromes. Most of the molecular studies of SERT in humans have been carried out using heterologous models. In this work, we have investigated the human enterocyte-like Caco-2 cell line as a potential "in vitro" model to study the human SERT. The results show that these cells express a SERT mRNA identical to the human brain SERT, and a 70 kDa protein immunodetected using a specific antibody. The SERT activity levels in Caco-2 cells increased in correlation with the onset and maintenance of the morphological and functional differentiation of the cells. Caco-2 SERT was also shown to be a high affinity (Kt=0.216 microM) saturable, Na(+) -dependent transporter that was inhibited by fluoxetine (IC(50)=17.6 nM). In addition, SERT activity was inhibited by the intracellular modulators protein kinase C and cAMP, either after short or long-term treatment. In short, the expression and molecular characteristics of the human SERT in Caco-2 cells indicate that this cell line may be an ideal tool to study in vitro the physiology and pharmacology of human SERT.
血清素转运体(SERT)已证明自身是治疗情绪障碍和某些胃肠道综合征的有效药理学靶点。大多数关于人类SERT的分子研究都是使用异源模型进行的。在这项工作中,我们研究了人肠上皮样Caco-2细胞系作为研究人类SERT的潜在“体外”模型。结果表明,这些细胞表达的SERT mRNA与人类大脑SERT相同,并且使用特异性抗体可免疫检测到一种70 kDa的蛋白质。Caco-2细胞中的SERT活性水平与细胞形态和功能分化的开始及维持相关增加。Caco-2 SERT还被证明是一种高亲和力(Kt = 0.216 microM)、可饱和的、依赖Na(+)的转运体,可被氟西汀抑制(IC(50)=17.6 nM)。此外,短期或长期处理后,细胞内调节剂蛋白激酶C和cAMP均可抑制SERT活性。简而言之,Caco-2细胞中人类SERT的表达和分子特征表明,该细胞系可能是体外研究人类SERT生理学和药理学的理想工具。